S&P 500 Futures
(0.08%) 5 331.50 points
Dow Jones Futures
(0.01%) 40 142 points
Nasdaq Futures
(0.12%) 18 657 points
Oil
(-0.29%) $79.83
Gas
(0.46%) $2.64
Gold
(1.28%) $2 448.30
Silver
(2.90%) $32.17
Platinum
(0.26%) $1 092.80
USD/EUR
(0.02%) $0.920
USD/NOK
(0.00%) $10.68
USD/GBP
(0.01%) $0.787
USD/RUB
(-0.31%) $90.68

Realtime updates for Bright Minds Biosciences [DRUG]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-20)

Expected move: +/- 11.26%

Last Updated17 May 2024 @ 16:00

0.92% $ 1.100

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases...

Stats
Today's Volume 10 666.00
Average Volume 20 992.00
Market Cap 4.75M
EPS $0 ( 2024-02-06 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.850
ATR14 $0.0310 (2.82%)

Bright Minds Biosciences Correlation

10 Most Positive Correlations
WKME0.963
ASTR0.947
NEPH0.935
EEIQ0.933
UONEK0.932
AEI0.932
TELA0.932
BSBK0.929
SOFO0.928
ARKO0.927
10 Most Negative Correlations
PUBM-0.935
IINN-0.93
BZ-0.926
JAN-0.924
LFMDP-0.921
ROOT-0.92
EBAY-0.92
PPC-0.916
BNR-0.914
KNTK-0.913

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bright Minds Biosciences Financials

Annual 2023
Revenue: $0
Gross Profit: $-72 450.00 (0.00 %)
EPS: $-1.980
FY 2023
Revenue: $0
Gross Profit: $-72 450.00 (0.00 %)
EPS: $-1.980
FY 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0
FY 2022
Revenue: $0
Gross Profit: $-6 037.00 (0.00 %)
EPS: $-6.15

Financial Reports:

No articles found.

Bright Minds Biosciences Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Bright Minds Biosciences

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators